Effects of Early Inhaled Epoprostenol Therapy on Pulmonary Artery Pressure and Blood Loss During LVAD Placement

Objective Several strategies have been used to reduce the incidence of right ventricular failure after left ventricular assist device (LVAD) placement, including pulmonary vasodilation. The inhaled prostacyclin, epoprostenol, selectively dilates the pulmonary vasculature of ventilated areas of the l...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiothoracic and vascular anesthesia Vol. 28; no. 3; pp. 652 - 660
Main Authors Groves, Danja S., MD, PhD, Blum, Franziska E., MD, Huffmyer, Julie L., MD, Kennedy, Jamie L.W., MD, Ahmad, Hasan B., BS, Durieux, Marcel E., MD, PhD, Kern, John A., MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective Several strategies have been used to reduce the incidence of right ventricular failure after left ventricular assist device (LVAD) placement, including pulmonary vasodilation. The inhaled prostacyclin, epoprostenol, selectively dilates the pulmonary vasculature of ventilated areas of the lung, but also has been shown to inhibit platelet aggregation.1 The authors evaluated the impact of early initiation of epoprostenol administration during LVAD placement on pulmonary artery pressures, use of vasoactive drugs, and blood loss. Design Retrospective data review. Setting Single center, university hospital. Participants A total of 37 consecutive patients undergoing LVAD (HeartMate II) placement were included. Interventions In the first group of 23 patients (group 1), inhaled epoprostenol was not initiated until weaning from cardiopulmonary bypass (CPB). In a subsequent group of 14 patients (group 2), inhaled epoprostenol was started shortly after induction of anesthesia and continued throughout and post-CPB. Measurements Mean and systolic pulmonary artery pressures (mPAP, sPAP), vasoactive drugs, as well as hemodynamic parameters, blood loss, and use of blood products were recorded at the following time points: Baseline (BL), pre-CPB, post-CPB, and during postoperative days (POD) 0, 1, and 2. Data are presented as mean±SD or median [25%, 75%]. Results Groups did not differ in demographic characteristics and comorbidities. BL sPAP (41±13 v 46±15 mmHg; p = 0.051) and mPAP (32±8 v 34±8 mmHg; p = 0.483) values were not different between the groups. Systolic and mPAP in group 1 were significantly lower in the postoperative period compared with BL (sPAP on POD 0: 34±6 mmHg; p<0.001; mPAP on POD 0, 1, and 2: 24±4 mmHg, 25±4 mmHg, 27±6 mmHg; p<0.001-0.003)). In contrast, in group 2, sPAP as well as mPAP were significantly lower during weaning from CPB (sPAP: 37±8; p = 0.002; mPAP: 28±5 mmHg; p = 0.016) as well as in the postoperative period (sPAP on POD 0, 1 and 2: 34±7, 35±7, and 37±10 mmHg; p<0.001-0.004; mPAP on POD 0, 1, and 2: 24±4 mmHg, 25±5 mmHg, 27±6 mmHg; p<0.001-0.006). Blood loss on postoperative day 0 was significantly lower in group 1 (1646 mL [1137, 2300] v 2915 mL [2335, 6155]; p = 0.006). Epoprostenol was a significant predictor of blood loss in the regression model (p<0.001) but did not predict a change in sPAP. Conclusions Inhaled prostacyclin reduces sPAP and mPAP in the postoperative period after LVAD placement regardless of the timing of initiation. Early initiation seems to reduce sPAP as well as mPAP more effectively during the weaning process from CPB. However, early initiation is associated with an increased blood loss in the immediate postoperative period. The concept of preventively “bathing” the lung in prostacyclin should be evaluated critically in a prospective fashion to adequately examine this question.
AbstractList OBJECTIVESeveral strategies have been used to reduce the incidence of right ventricular failure after left ventricular assist device (LVAD) placement, including pulmonary vasodilation. The inhaled prostacyclin, epoprostenol, selectively dilates the pulmonary vasculature of ventilated areas of the lung, but also has been shown to inhibit platelet aggregation.(1) The authors evaluated the impact of early initiation of epoprostenol administration during LVAD placement on pulmonary artery pressures, use of vasoactive drugs, and blood loss.DESIGNRetrospective data review.SETTINGSingle center, university hospital.PARTICIPANTSA total of 37 consecutive patients undergoing LVAD (HeartMate II) placement were included.INTERVENTIONSIn the first group of 23 patients (group 1), inhaled epoprostenol was not initiated until weaning from cardiopulmonary bypass (CPB). In a subsequent group of 14 patients (group 2), inhaled epoprostenol was started shortly after induction of anesthesia and continued throughout and post-CPB.MEASUREMENTSMean and systolic pulmonary artery pressures (mPAP, sPAP), vasoactive drugs, as well as hemodynamic parameters, blood loss, and use of blood products were recorded at the following time points: Baseline (BL), pre-CPB, post-CPB, and during postoperative days (POD) 0, 1, and 2. Data are presented as mean±SD or median [25%, 75%].RESULTSGroups did not differ in demographic characteristics and comorbidities. BL sPAP (41±13 v 46±15 mmHg; p = 0.051) and mPAP (32±8 v 34±8 mmHg; p = 0.483) values were not different between the groups. Systolic and mPAP in group 1 were significantly lower in the postoperative period compared with BL (sPAP on POD 0: 34±6 mmHg; p<0.001; mPAP on POD 0, 1, and 2: 24±4 mmHg, 25±4 mmHg, 27±6 mmHg; p<0.001-0.003)). In contrast, in group 2, sPAP as well as mPAP were significantly lower during weaning from CPB (sPAP: 37±8; p = 0.002; mPAP: 28±5 mmHg; p = 0.016) as well as in the postoperative period (sPAP on POD 0, 1 and 2: 34±7, 35±7, and 37±10 mmHg; p<0.001-0.004; mPAP on POD 0, 1, and 2: 24±4 mmHg, 25±5 mmHg, 27±6 mmHg; p<0.001-0.006). Blood loss on postoperative day 0 was significantly lower in group 1 (1646 mL [1137, 2300] v 2915 mL [2335, 6155]; p = 0.006). Epoprostenol was a significant predictor of blood loss in the regression model (p<0.001) but did not predict a change in sPAP.CONCLUSIONSInhaled prostacyclin reduces sPAP and mPAP in the postoperative period after LVAD placement regardless of the timing of initiation. Early initiation seems to reduce sPAP as well as mPAP more effectively during the weaning process from CPB. However, early initiation is associated with an increased blood loss in the immediate postoperative period. The concept of preventively "bathing" the lung in prostacyclin should be evaluated critically in a prospective fashion to adequately examine this question.
Several strategies have been used to reduce the incidence of right ventricular failure after left ventricular assist device (LVAD) placement, including pulmonary vasodilation. The inhaled prostacyclin, epoprostenol, selectively dilates the pulmonary vasculature of ventilated areas of the lung, but also has been shown to inhibit platelet aggregation.(1) The authors evaluated the impact of early initiation of epoprostenol administration during LVAD placement on pulmonary artery pressures, use of vasoactive drugs, and blood loss. Retrospective data review. Single center, university hospital. A total of 37 consecutive patients undergoing LVAD (HeartMate II) placement were included. In the first group of 23 patients (group 1), inhaled epoprostenol was not initiated until weaning from cardiopulmonary bypass (CPB). In a subsequent group of 14 patients (group 2), inhaled epoprostenol was started shortly after induction of anesthesia and continued throughout and post-CPB. Mean and systolic pulmonary artery pressures (mPAP, sPAP), vasoactive drugs, as well as hemodynamic parameters, blood loss, and use of blood products were recorded at the following time points: Baseline (BL), pre-CPB, post-CPB, and during postoperative days (POD) 0, 1, and 2. Data are presented as mean±SD or median [25%, 75%]. Groups did not differ in demographic characteristics and comorbidities. BL sPAP (41±13 v 46±15 mmHg; p = 0.051) and mPAP (32±8 v 34±8 mmHg; p = 0.483) values were not different between the groups. Systolic and mPAP in group 1 were significantly lower in the postoperative period compared with BL (sPAP on POD 0: 34±6 mmHg; p<0.001; mPAP on POD 0, 1, and 2: 24±4 mmHg, 25±4 mmHg, 27±6 mmHg; p<0.001-0.003)). In contrast, in group 2, sPAP as well as mPAP were significantly lower during weaning from CPB (sPAP: 37±8; p = 0.002; mPAP: 28±5 mmHg; p = 0.016) as well as in the postoperative period (sPAP on POD 0, 1 and 2: 34±7, 35±7, and 37±10 mmHg; p<0.001-0.004; mPAP on POD 0, 1, and 2: 24±4 mmHg, 25±5 mmHg, 27±6 mmHg; p<0.001-0.006). Blood loss on postoperative day 0 was significantly lower in group 1 (1646 mL [1137, 2300] v 2915 mL [2335, 6155]; p = 0.006). Epoprostenol was a significant predictor of blood loss in the regression model (p<0.001) but did not predict a change in sPAP. Inhaled prostacyclin reduces sPAP and mPAP in the postoperative period after LVAD placement regardless of the timing of initiation. Early initiation seems to reduce sPAP as well as mPAP more effectively during the weaning process from CPB. However, early initiation is associated with an increased blood loss in the immediate postoperative period. The concept of preventively "bathing" the lung in prostacyclin should be evaluated critically in a prospective fashion to adequately examine this question.
Objective Several strategies have been used to reduce the incidence of right ventricular failure after left ventricular assist device (LVAD) placement, including pulmonary vasodilation. The inhaled prostacyclin, epoprostenol, selectively dilates the pulmonary vasculature of ventilated areas of the lung, but also has been shown to inhibit platelet aggregation.1 The authors evaluated the impact of early initiation of epoprostenol administration during LVAD placement on pulmonary artery pressures, use of vasoactive drugs, and blood loss. Design Retrospective data review. Setting Single center, university hospital. Participants A total of 37 consecutive patients undergoing LVAD (HeartMate II) placement were included. Interventions In the first group of 23 patients (group 1), inhaled epoprostenol was not initiated until weaning from cardiopulmonary bypass (CPB). In a subsequent group of 14 patients (group 2), inhaled epoprostenol was started shortly after induction of anesthesia and continued throughout and post-CPB. Measurements Mean and systolic pulmonary artery pressures (mPAP, sPAP), vasoactive drugs, as well as hemodynamic parameters, blood loss, and use of blood products were recorded at the following time points: Baseline (BL), pre-CPB, post-CPB, and during postoperative days (POD) 0, 1, and 2. Data are presented as mean±SD or median [25%, 75%]. Results Groups did not differ in demographic characteristics and comorbidities. BL sPAP (41±13 v 46±15 mmHg; p = 0.051) and mPAP (32±8 v 34±8 mmHg; p = 0.483) values were not different between the groups. Systolic and mPAP in group 1 were significantly lower in the postoperative period compared with BL (sPAP on POD 0: 34±6 mmHg; p<0.001; mPAP on POD 0, 1, and 2: 24±4 mmHg, 25±4 mmHg, 27±6 mmHg; p<0.001-0.003)). In contrast, in group 2, sPAP as well as mPAP were significantly lower during weaning from CPB (sPAP: 37±8; p = 0.002; mPAP: 28±5 mmHg; p = 0.016) as well as in the postoperative period (sPAP on POD 0, 1 and 2: 34±7, 35±7, and 37±10 mmHg; p<0.001-0.004; mPAP on POD 0, 1, and 2: 24±4 mmHg, 25±5 mmHg, 27±6 mmHg; p<0.001-0.006). Blood loss on postoperative day 0 was significantly lower in group 1 (1646 mL [1137, 2300] v 2915 mL [2335, 6155]; p = 0.006). Epoprostenol was a significant predictor of blood loss in the regression model (p<0.001) but did not predict a change in sPAP. Conclusions Inhaled prostacyclin reduces sPAP and mPAP in the postoperative period after LVAD placement regardless of the timing of initiation. Early initiation seems to reduce sPAP as well as mPAP more effectively during the weaning process from CPB. However, early initiation is associated with an increased blood loss in the immediate postoperative period. The concept of preventively “bathing” the lung in prostacyclin should be evaluated critically in a prospective fashion to adequately examine this question.
Author Ahmad, Hasan B., BS
Kennedy, Jamie L.W., MD
Groves, Danja S., MD, PhD
Huffmyer, Julie L., MD
Blum, Franziska E., MD
Durieux, Marcel E., MD, PhD
Kern, John A., MD
Author_xml – sequence: 1
  fullname: Groves, Danja S., MD, PhD
– sequence: 2
  fullname: Blum, Franziska E., MD
– sequence: 3
  fullname: Huffmyer, Julie L., MD
– sequence: 4
  fullname: Kennedy, Jamie L.W., MD
– sequence: 5
  fullname: Ahmad, Hasan B., BS
– sequence: 6
  fullname: Durieux, Marcel E., MD, PhD
– sequence: 7
  fullname: Kern, John A., MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24103713$$D View this record in MEDLINE/PubMed
BookMark eNp9kc2LFDEQxYOsuB_6D3iQHL10W_noSQ-IMO6OujDggKvXkElX3G4zyWzSvTD_vWlm9eBB6lB1eO_B-9UlOQsxICGvGdQMGvFuqIdHa2oOTNTQ1MDbZ-SCNYJXreT8rNxFVYFScE4ucx4AGGsa9YKcc8lAKCYuSFw7h3bMNDq6Nskf6W24Nx47uj7EQ4p5xBA9vbvHZA5HGgPdTn4fg0lHukojlrVNmPOUkJrQ0Y8-xo5uYs70Zkp9-Ek3P1Y3dOuNxT2G8SV57ozP-OppX5Hvn9Z311-qzdfPt9erTWWlUmNlODrkisnGSQ5L1-244rZtQTrVcqYWRqqdsFIsZbNwDBbSLJZKCOkcKOeW4oq8PeWWDg8T5lHv-2zRexMwTlkXTA1nkrNZyk9SW-rmhE4fUr8vBTUDPSPUg55B6xm0hkYX0MX05il_2u2x-2v5Q7YI3p8EWFo-9ph0tj0Gi12fCnDdxf7_-R_-sVvfh94a_wuPmIc4pVD4aaYz16C_zTnzp5kAEPP8BoydpIY
CitedBy_id crossref_primary_10_1055_s_0042_1756178
crossref_primary_10_1177_1089253217749298
crossref_primary_10_3389_fcvm_2022_1040251
crossref_primary_10_1053_j_jvca_2017_12_014
crossref_primary_10_1007_s12630_023_02520_4
crossref_primary_10_1002_phar_1959
crossref_primary_10_1007_s40140_015_0127_4
crossref_primary_10_1007_s11936_016_0438_x
crossref_primary_10_1016_j_ccc_2018_03_001
crossref_primary_10_1213_ANE_0000000000006192
crossref_primary_10_1016_j_bpa_2015_04_003
crossref_primary_10_1097_MAT_0000000000002023
crossref_primary_10_1093_ejcts_ezz098
crossref_primary_10_1002_ehf2_13322
crossref_primary_10_1002_phar_2491
crossref_primary_10_1016_j_pharmthera_2020_107619
crossref_primary_10_1016_j_rmed_2017_08_006
crossref_primary_10_1253_circj_CJ_15_0093
crossref_primary_10_1053_j_jvca_2020_04_015
crossref_primary_10_1007_s11897_018_0389_5
crossref_primary_10_1007_s40140_020_00411_8
Cites_doi 10.1161/01.CIR.95.9.2250
10.1016/j.healun.2008.09.006
10.1016/j.healun.2005.07.002
10.1097/00005344-199604000-00019
10.1378/chest.117.3.819
10.1016/S0022-5223(96)70337-9
10.1510/icvts.2006.128322
10.1016/S0003-4975(99)00753-5
10.1378/chest.07-1367
10.1007/BF00586592
10.1016/S0003-4975(97)01307-6
10.1016/j.ejcts.2011.05.047
10.1378/chest.126.4.1313
10.1159/000194653
10.1016/j.athoracsur.2003.09.048
10.1164/ajrccm/146.2.383
10.1016/S0022-5223(97)70416-1
10.1007/s12265-010-9216-4
10.1016/j.thromres.2010.01.048
10.1161/01.cir.0000032906.33237.1c
10.1007/s001340051027
10.1067/mtc.2003.107
10.1016/0090-6980(76)90048-4
10.1016/j.jtcvs.2009.11.020
10.1055/s-0038-1646791
10.1203/00006450-199508000-00011
10.1161/CIRCULATIONAHA.108.844274
10.1378/chest.114.3.780
10.1016/j.healun.2005.07.008
10.1016/0090-6980(78)90059-X
10.1164/ajrccm.160.2.9810008
10.1016/j.echo.2005.12.020
10.1016/j.jtcvs.2005.09.031
10.1016/j.jacc.2008.03.009
10.1160/TH07-11-0673
10.1161/01.CIR.61.3.626
10.1159/000129297
10.1016/S0735-1097(00)01102-5
10.1007/s001340050044
10.1007/s11936-010-0091-8
10.1016/S1053-0770(96)80047-4
10.1016/j.jtcvs.2003.11.035
10.1093/oxfordjournals.eurheartj.a015478
10.1097/00003246-198305000-00002
10.1007/BF03017361
ContentType Journal Article
Copyright Elsevier Inc.
2014 Elsevier Inc.
Copyright © 2014 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Elsevier Inc.
– notice: 2014 Elsevier Inc.
– notice: Copyright © 2014 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1053/j.jvca.2013.05.028
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-8422
EndPage 660
ExternalDocumentID 10_1053_j_jvca_2013_05_028
24103713
S1053077013003030
1_s2_0_S1053077013003030
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAXKI
AAXUO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
M29
M41
MO0
N9A
O-L
O9-
O90
OAUVE
OL-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSZ
T5K
UHS
UNMZH
UV1
WUQ
Z5R
~G-
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACRPL
ADNMO
CITATION
7X8
ID FETCH-LOGICAL-c477t-a2efe27145f4209fdb272c8804f782176a47b3c439456f1064a697334ff07ff93
IEDL.DBID .~1
ISSN 1053-0770
IngestDate Sat Oct 26 01:17:25 EDT 2024
Fri Dec 06 04:01:53 EST 2024
Sat Sep 28 07:52:27 EDT 2024
Fri Feb 23 02:31:41 EST 2024
Tue Oct 15 22:54:08 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords left ventricular assist device
pulmonary artery pressure
prostacyclin
blood loss
inhaled epoprostenol
Language English
License Copyright © 2014 Elsevier Inc. All rights reserved.
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c477t-a2efe27145f4209fdb272c8804f782176a47b3c439456f1064a697334ff07ff93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24103713
PQID 1535214219
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1535214219
crossref_primary_10_1053_j_jvca_2013_05_028
pubmed_primary_24103713
elsevier_sciencedirect_doi_10_1053_j_jvca_2013_05_028
elsevier_clinicalkeyesjournals_1_s2_0_S1053077013003030
PublicationCentury 2000
PublicationDate 2014-06-01
PublicationDateYYYYMMDD 2014-06-01
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of cardiothoracic and vascular anesthesia
PublicationTitleAlternate J Cardiothorac Vasc Anesth
PublicationYear 2014
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Zobel, Dacar, Rodl (bib28) 1995; 38
Hare, Shernan, Body (bib24) 1997; 95
Haraldsson, Kieler-Jensen, Wadenvik (bib1) 2000; 26
Fukamachi, McCarthy, Smedira (bib9) 1999; 68
Max, Kuhlen, Dembinski (bib29) 1999; 25
Brinker, Weiss, Lappe (bib18) 1980; 61
Mikhail, Gibbs, Richardson (bib33) 1997; 18
Fitzpatrick, Frederick, Hsu (bib16) 2008; 27
Hache, Denault, Belisle (bib37) 2003; 125
Accessed Jan, 2013
Hache, Denault, Belisle (bib30) 2001; 48
Krishan, Nair, Pinney (bib22) 2012; 41
Potapov, Meyer, Swaminathan (bib26) 2011; 30
Farrar, Hill, Pennington (bib8) 1997; 113
Syyed, Reeves, Welsh (bib40) 2008; 133
Wagner, Dandel, Gunther (bib25) 1997; 96
Moncada, Gryglewski, Bunting (bib42) 1976; 12
Roger, Go, Lloyd-Jones (bib2) 2012; 125
Arcangeli, Rocca, Salvatori (bib46) 2010; 126
Weber, Janicki, Shroff (bib20) 1983; 11
Matthews, Koelling, Pagani (bib15) 2008; 51
Argenziano, Choudhri, Moazami (bib23) 1998; 65
Gryglewski, Korbut, Ocetkiewicz (bib45) 1978; 302
Dang, Topkara, Mercando (bib12) 2006; 25
John, Lee, Eckman (bib4) 2010; 3
Gachet (bib47) 2008; 99
Morgan, John, Lee (bib6) 2004; 77
van Heerden, Barden, Michalopoulos (bib49) 2000; 117
O'Doherty, Thomas, Page (bib50) 1992; 146
Ghio, Gavazzi, Campana (bib38) 2001; 37
Deng, Edwards, Hertz (bib11) 2005; 24
Schenk, McCarthy, Blackstone (bib14) 2006; 131
Ubatuba, Moncada, Vane (bib43) 1979; 41
Santambrogio, Bianchi, Fuardo (bib13) 2006; 5
Ochiai, McCarthy, Smedira (bib10) 2002; 106
Friedberg, Feinstein, Rosenthal (bib41) 2006; 19
Burghuber, Silberbauer, Haber (bib48) 1984; 45
Olschewski, Ghofrani, Walmrath (bib32) 1999; 160
Romano, Cowger, Aaronson (bib17) 2010; 12
Haraldsson, Kieler-Jensen, Nathorst-Westfelt (bib35) 1998; 114
Chemla, Castelain, Humbert (bib39) 2004; 126
Haraldsson, Kieler-Jensen, Ricksten (bib34) 1996; 10
Welte, Zwissler, Habazettl (bib27) 1993; 25
FierceMedical Devices. Thoratec announces FDA approval to commence REVIVE-IT study utilizing HeartMate II. Available at
Bein, Metz, Keyl, Sendtner (bib31) 1996; 27
Kormos, Gasior, Kawai (bib7) 1996; 111
Ari, Areabi, Fink (bib51) 2010; 55
Kormos, Teuteberg, Pagani (bib5) 2010; 139
Hendry, Ascah, Rajagopalan (bib19) 1994; 90
Pal, Klodell, John (bib21) 2009; 120
Gryglewski, Korbut, Ocetkiewicz (bib44) 1978; 15
De Wet, Affleck, Jacobsohn (bib36) 2004; 127
Argenziano (10.1053/j.jvca.2013.05.028_bib23) 1998; 65
Mikhail (10.1053/j.jvca.2013.05.028_bib33) 1997; 18
Kormos (10.1053/j.jvca.2013.05.028_bib7) 1996; 111
Haraldsson (10.1053/j.jvca.2013.05.028_bib1) 2000; 26
Schenk (10.1053/j.jvca.2013.05.028_bib14) 2006; 131
Zobel (10.1053/j.jvca.2013.05.028_bib28) 1995; 38
Chemla (10.1053/j.jvca.2013.05.028_bib39) 2004; 126
Olschewski (10.1053/j.jvca.2013.05.028_bib32) 1999; 160
Pal (10.1053/j.jvca.2013.05.028_bib21) 2009; 120
Friedberg (10.1053/j.jvca.2013.05.028_bib41) 2006; 19
Deng (10.1053/j.jvca.2013.05.028_bib11) 2005; 24
Gryglewski (10.1053/j.jvca.2013.05.028_bib45) 1978; 302
Hendry (10.1053/j.jvca.2013.05.028_bib19) 1994; 90
10.1053/j.jvca.2013.05.028_bib3
Morgan (10.1053/j.jvca.2013.05.028_bib6) 2004; 77
Hare (10.1053/j.jvca.2013.05.028_bib24) 1997; 95
Farrar (10.1053/j.jvca.2013.05.028_bib8) 1997; 113
Ghio (10.1053/j.jvca.2013.05.028_bib38) 2001; 37
Romano (10.1053/j.jvca.2013.05.028_bib17) 2010; 12
Syyed (10.1053/j.jvca.2013.05.028_bib40) 2008; 133
Gachet (10.1053/j.jvca.2013.05.028_bib47) 2008; 99
Wagner (10.1053/j.jvca.2013.05.028_bib25) 1997; 96
Burghuber (10.1053/j.jvca.2013.05.028_bib48) 1984; 45
Bein (10.1053/j.jvca.2013.05.028_bib31) 1996; 27
De Wet (10.1053/j.jvca.2013.05.028_bib36) 2004; 127
Weber (10.1053/j.jvca.2013.05.028_bib20) 1983; 11
Potapov (10.1053/j.jvca.2013.05.028_bib26) 2011; 30
Ari (10.1053/j.jvca.2013.05.028_bib51) 2010; 55
Fitzpatrick (10.1053/j.jvca.2013.05.028_bib16) 2008; 27
Brinker (10.1053/j.jvca.2013.05.028_bib18) 1980; 61
John (10.1053/j.jvca.2013.05.028_bib4) 2010; 3
Max (10.1053/j.jvca.2013.05.028_bib29) 1999; 25
Haraldsson (10.1053/j.jvca.2013.05.028_bib34) 1996; 10
Hache (10.1053/j.jvca.2013.05.028_bib37) 2003; 125
Hache (10.1053/j.jvca.2013.05.028_bib30) 2001; 48
Ochiai (10.1053/j.jvca.2013.05.028_bib10) 2002; 106
O'Doherty (10.1053/j.jvca.2013.05.028_bib50) 1992; 146
Dang (10.1053/j.jvca.2013.05.028_bib12) 2006; 25
Welte (10.1053/j.jvca.2013.05.028_bib27) 1993; 25
Arcangeli (10.1053/j.jvca.2013.05.028_bib46) 2010; 126
Gryglewski (10.1053/j.jvca.2013.05.028_bib44) 1978; 15
Moncada (10.1053/j.jvca.2013.05.028_bib42) 1976; 12
van Heerden (10.1053/j.jvca.2013.05.028_bib49) 2000; 117
Roger (10.1053/j.jvca.2013.05.028_bib2) 2012; 125
Haraldsson (10.1053/j.jvca.2013.05.028_bib35) 1998; 114
Krishan (10.1053/j.jvca.2013.05.028_bib22) 2012; 41
Kormos (10.1053/j.jvca.2013.05.028_bib5) 2010; 139
Fukamachi (10.1053/j.jvca.2013.05.028_bib9) 1999; 68
Santambrogio (10.1053/j.jvca.2013.05.028_bib13) 2006; 5
Matthews (10.1053/j.jvca.2013.05.028_bib15) 2008; 51
Ubatuba (10.1053/j.jvca.2013.05.028_bib43) 1979; 41
References_xml – volume: 51
  start-page: 2163
  year: 2008
  end-page: 2172
  ident: bib15
  article-title: The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Pagani
– volume: 125
  start-page: e2
  year: 2012
  end-page: e220
  ident: bib2
  article-title: Heart disease and stroke statistics--2012 update: A report from the American
  publication-title: Heart Association. Circulation
  contributor:
    fullname: Lloyd-Jones
– volume: 38
  start-page: 198
  year: 1995
  end-page: 204
  ident: bib28
  article-title: Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets
  publication-title: Pediatr Res
  contributor:
    fullname: Rodl
– volume: 27
  start-page: 583
  year: 1996
  end-page: 586
  ident: bib31
  article-title: Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator nebulization system
  publication-title: J Cardiovasc Pharmacol
  contributor:
    fullname: Sendtner
– volume: 61
  start-page: 626
  year: 1980
  end-page: 633
  ident: bib18
  article-title: Leftward septal displacement during right ventricular loading in man
  publication-title: Circulation
  contributor:
    fullname: Lappe
– volume: 37
  start-page: 183
  year: 2001
  end-page: 188
  ident: bib38
  article-title: Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Campana
– volume: 26
  start-page: 188
  year: 2000
  end-page: 194
  ident: bib1
  article-title: Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass
  publication-title: Intensive Care Med
  contributor:
    fullname: Wadenvik
– volume: 127
  start-page: 1058
  year: 2004
  end-page: 1067
  ident: bib36
  article-title: Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Jacobsohn
– volume: 68
  start-page: 2181
  year: 1999
  end-page: 2184
  ident: bib9
  article-title: Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion
  publication-title: Ann Thorac Surg
  contributor:
    fullname: Smedira
– volume: 12
  start-page: 420
  year: 2010
  end-page: 430
  ident: bib17
  article-title: Diagnosis and management of right-sided heart failure in subjects supported with left ventricular assist devices
  publication-title: Curr Treat Options Cardiovasc Med
  contributor:
    fullname: Aaronson
– volume: 95
  start-page: 2250
  year: 1997
  end-page: 2253
  ident: bib24
  article-title: Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance
  publication-title: Circulation
  contributor:
    fullname: Body
– volume: 65
  start-page: 340
  year: 1998
  end-page: 345
  ident: bib23
  article-title: Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension
  publication-title: Ann Thorac Surg
  contributor:
    fullname: Moazami
– volume: 160
  start-page: 600
  year: 1999
  end-page: 607
  ident: bib32
  article-title: Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis
  publication-title: Am J Respir Crit Care Med
  contributor:
    fullname: Walmrath
– volume: 133
  start-page: 633
  year: 2008
  end-page: 639
  ident: bib40
  article-title: The relationship between the components of pulmonary artery pressure remains constant under all conditions in both health and disease
  publication-title: Chest
  contributor:
    fullname: Welsh
– volume: 96
  start-page: 291
  year: 1997
  end-page: 296
  ident: bib25
  article-title: Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation
  publication-title: Circulation
  contributor:
    fullname: Gunther
– volume: 18
  start-page: 1499
  year: 1997
  end-page: 1504
  ident: bib33
  article-title: An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension
  publication-title: Eur Heart J
  contributor:
    fullname: Richardson
– volume: 3
  start-page: 604
  year: 2010
  end-page: 611
  ident: bib4
  article-title: Right ventricular failure—A continuing problem in patients with left ventricular assist device support
  publication-title: J Cardiovasc Transl Res
  contributor:
    fullname: Eckman
– volume: 120
  start-page: S215
  year: 2009
  end-page: S219
  ident: bib21
  article-title: Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures
  publication-title: Circulation
  contributor:
    fullname: John
– volume: 24
  start-page: 1182
  year: 2005
  end-page: 1187
  ident: bib11
  article-title: Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: Third annual report--2005
  publication-title: J Heart Lung Transplant
  contributor:
    fullname: Hertz
– volume: 5
  start-page: 379
  year: 2006
  end-page: 382
  ident: bib13
  article-title: Right ventricular failure after left ventricular assist device insertion: Preoperative risk factors
  publication-title: Interact Cardiovasc Thorac Surg
  contributor:
    fullname: Fuardo
– volume: 146
  start-page: 383
  year: 1992
  end-page: 388
  ident: bib50
  article-title: Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill
  publication-title: Am Rev Respir Dis
  contributor:
    fullname: Page
– volume: 10
  start-page: 864
  year: 1996
  end-page: 868
  ident: bib34
  article-title: Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: A pharmacodynamic study
  publication-title: J Cardiothorac Vasc Anesth
  contributor:
    fullname: Ricksten
– volume: 12
  start-page: 715
  year: 1976
  end-page: 737
  ident: bib42
  article-title: A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  publication-title: Prostaglandins
  contributor:
    fullname: Bunting
– volume: 90
  start-page: 353
  year: 1994
  end-page: 358
  ident: bib19
  article-title: Does septal position affect right ventricular function during left ventricular assist in an experimental porcine model?
  publication-title: Circulation
  contributor:
    fullname: Rajagopalan
– volume: 113
  start-page: 202
  year: 1997
  end-page: 209
  ident: bib8
  article-title: Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Pennington
– volume: 106
  start-page: I198
  year: 2002
  end-page: I202
  ident: bib10
  article-title: Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: Analysis of 245 patients
  publication-title: Circulation
  contributor:
    fullname: Smedira
– volume: 114
  start-page: 780
  year: 1998
  end-page: 786
  ident: bib35
  article-title: Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance
  publication-title: Chest
  contributor:
    fullname: Nathorst-Westfelt
– volume: 139
  start-page: 1316
  year: 2010
  end-page: 1324
  ident: bib5
  article-title: Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Pagani
– volume: 41
  start-page: 213
  year: 2012
  end-page: 217
  ident: bib22
  article-title: Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation
  publication-title: Eur J Cardiothorac Surg
  contributor:
    fullname: Pinney
– volume: 25
  start-page: 1147
  year: 1999
  end-page: 1154
  ident: bib29
  article-title: Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension
  publication-title: Intensive Care Med
  contributor:
    fullname: Dembinski
– volume: 19
  start-page: 559
  year: 2006
  end-page: 562
  ident: bib41
  article-title: A novel echocardiographic Doppler method for estimation of pulmonary arterial pressures
  publication-title: J Am Soc Echocardiogr
  contributor:
    fullname: Rosenthal
– volume: 27
  start-page: 1286
  year: 2008
  end-page: 1292
  ident: bib16
  article-title: Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support
  publication-title: J Heart Lung Transplant
  contributor:
    fullname: Hsu
– volume: 126
  start-page: 1313
  year: 2004
  end-page: 1317
  ident: bib39
  article-title: New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure
  publication-title: Chest
  contributor:
    fullname: Humbert
– volume: 99
  start-page: 466
  year: 2008
  end-page: 472
  ident: bib47
  article-title: P2 receptors, platelet function and pharmacological implications
  publication-title: Thromb Haemost
  contributor:
    fullname: Gachet
– volume: 111
  start-page: 773
  year: 1996
  end-page: 782
  ident: bib7
  article-title: Transplant candidate’s clinical status rather than right ventricular function defines need for univentricular versus biventricular support
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Kawai
– volume: 25
  start-page: 1
  year: 2006
  end-page: 6
  ident: bib12
  article-title: Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure
  publication-title: J Heart Lung Transplant
  contributor:
    fullname: Mercando
– volume: 77
  start-page: 859
  year: 2004
  end-page: 863
  ident: bib6
  article-title: Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality
  publication-title: Ann Thorac Sur
  contributor:
    fullname: Lee
– volume: 30
  start-page: 870
  year: 2011
  end-page: 878
  ident: bib26
  article-title: Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial
  publication-title: J Heart Lung Transplant
  contributor:
    fullname: Swaminathan
– volume: 25
  start-page: 329
  year: 1993
  end-page: 340
  ident: bib27
  article-title: PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction
  publication-title: Eur Surg Res
  contributor:
    fullname: Habazettl
– volume: 126
  start-page: 24
  year: 2010
  end-page: 31
  ident: bib46
  article-title: Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter
  publication-title: Thromb Res
  contributor:
    fullname: Salvatori
– volume: 11
  start-page: 323
  year: 1983
  end-page: 328
  ident: bib20
  article-title: The right ventricle: Physiologic and pathophysiologic considerations
  publication-title: Crit Care Med
  contributor:
    fullname: Shroff
– volume: 302
  start-page: 25
  year: 1978
  end-page: 30
  ident: bib45
  article-title: In vivo method for quantitation for anti-platelet potency of drugs
  publication-title: Naunyn Schmiedebergs Arch Pharmacol
  contributor:
    fullname: Ocetkiewicz
– volume: 125
  start-page: 642
  year: 2003
  end-page: 649
  ident: bib37
  article-title: Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Belisle
– volume: 45
  start-page: 450
  year: 1984
  end-page: 454
  ident: bib48
  article-title: Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion
  publication-title: Respiration
  contributor:
    fullname: Haber
– volume: 55
  start-page: 837
  year: 2010
  end-page: 844
  ident: bib51
  article-title: Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation
  publication-title: Respir Care
  contributor:
    fullname: Fink
– volume: 131
  start-page: 447
  year: 2006
  end-page: 454
  ident: bib14
  article-title: Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Blackstone
– volume: 117
  start-page: 819
  year: 2000
  end-page: 827
  ident: bib49
  article-title: Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS
  publication-title: Chest
  contributor:
    fullname: Michalopoulos
– volume: 48
  start-page: 924
  year: 2001
  end-page: 929
  ident: bib30
  article-title: Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit
  publication-title: Can J Anaesth
  contributor:
    fullname: Belisle
– volume: 41
  start-page: 425
  year: 1979
  end-page: 435
  ident: bib43
  article-title: The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time
  publication-title: Thromb Haemost
  contributor:
    fullname: Vane
– volume: 15
  start-page: 637
  year: 1978
  end-page: 644
  ident: bib44
  article-title: De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline
  publication-title: Prostaglandins
  contributor:
    fullname: Ocetkiewicz
– volume: 95
  start-page: 2250
  year: 1997
  ident: 10.1053/j.jvca.2013.05.028_bib24
  article-title: Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance
  publication-title: Circulation
  doi: 10.1161/01.CIR.95.9.2250
  contributor:
    fullname: Hare
– volume: 27
  start-page: 1286
  year: 2008
  ident: 10.1053/j.jvca.2013.05.028_bib16
  article-title: Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support
  publication-title: J Heart Lung Transplant
  doi: 10.1016/j.healun.2008.09.006
  contributor:
    fullname: Fitzpatrick
– volume: 24
  start-page: 1182
  year: 2005
  ident: 10.1053/j.jvca.2013.05.028_bib11
  article-title: Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: Third annual report--2005
  publication-title: J Heart Lung Transplant
  doi: 10.1016/j.healun.2005.07.002
  contributor:
    fullname: Deng
– volume: 27
  start-page: 583
  year: 1996
  ident: 10.1053/j.jvca.2013.05.028_bib31
  article-title: Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator nebulization system
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/00005344-199604000-00019
  contributor:
    fullname: Bein
– volume: 117
  start-page: 819
  year: 2000
  ident: 10.1053/j.jvca.2013.05.028_bib49
  article-title: Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS
  publication-title: Chest
  doi: 10.1378/chest.117.3.819
  contributor:
    fullname: van Heerden
– volume: 111
  start-page: 773
  year: 1996
  ident: 10.1053/j.jvca.2013.05.028_bib7
  article-title: Transplant candidate’s clinical status rather than right ventricular function defines need for univentricular versus biventricular support
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/S0022-5223(96)70337-9
  contributor:
    fullname: Kormos
– volume: 5
  start-page: 379
  year: 2006
  ident: 10.1053/j.jvca.2013.05.028_bib13
  article-title: Right ventricular failure after left ventricular assist device insertion: Preoperative risk factors
  publication-title: Interact Cardiovasc Thorac Surg
  doi: 10.1510/icvts.2006.128322
  contributor:
    fullname: Santambrogio
– volume: 68
  start-page: 2181
  year: 1999
  ident: 10.1053/j.jvca.2013.05.028_bib9
  article-title: Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion
  publication-title: Ann Thorac Surg
  doi: 10.1016/S0003-4975(99)00753-5
  contributor:
    fullname: Fukamachi
– volume: 125
  start-page: e2
  year: 2012
  ident: 10.1053/j.jvca.2013.05.028_bib2
  article-title: Heart disease and stroke statistics--2012 update: A report from the American
  publication-title: Heart Association. Circulation
  contributor:
    fullname: Roger
– volume: 133
  start-page: 633
  year: 2008
  ident: 10.1053/j.jvca.2013.05.028_bib40
  article-title: The relationship between the components of pulmonary artery pressure remains constant under all conditions in both health and disease
  publication-title: Chest
  doi: 10.1378/chest.07-1367
  contributor:
    fullname: Syyed
– volume: 302
  start-page: 25
  year: 1978
  ident: 10.1053/j.jvca.2013.05.028_bib45
  article-title: In vivo method for quantitation for anti-platelet potency of drugs
  publication-title: Naunyn Schmiedebergs Arch Pharmacol
  doi: 10.1007/BF00586592
  contributor:
    fullname: Gryglewski
– volume: 65
  start-page: 340
  year: 1998
  ident: 10.1053/j.jvca.2013.05.028_bib23
  article-title: Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension
  publication-title: Ann Thorac Surg
  doi: 10.1016/S0003-4975(97)01307-6
  contributor:
    fullname: Argenziano
– volume: 41
  start-page: 213
  year: 2012
  ident: 10.1053/j.jvca.2013.05.028_bib22
  article-title: Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1016/j.ejcts.2011.05.047
  contributor:
    fullname: Krishan
– volume: 126
  start-page: 1313
  year: 2004
  ident: 10.1053/j.jvca.2013.05.028_bib39
  article-title: New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure
  publication-title: Chest
  doi: 10.1378/chest.126.4.1313
  contributor:
    fullname: Chemla
– volume: 45
  start-page: 450
  year: 1984
  ident: 10.1053/j.jvca.2013.05.028_bib48
  article-title: Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion
  publication-title: Respiration
  doi: 10.1159/000194653
  contributor:
    fullname: Burghuber
– volume: 96
  start-page: 291
  year: 1997
  ident: 10.1053/j.jvca.2013.05.028_bib25
  article-title: Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation
  publication-title: Circulation
  contributor:
    fullname: Wagner
– volume: 77
  start-page: 859
  year: 2004
  ident: 10.1053/j.jvca.2013.05.028_bib6
  article-title: Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality
  publication-title: Ann Thorac Sur
  doi: 10.1016/j.athoracsur.2003.09.048
  contributor:
    fullname: Morgan
– volume: 146
  start-page: 383
  year: 1992
  ident: 10.1053/j.jvca.2013.05.028_bib50
  article-title: Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/146.2.383
  contributor:
    fullname: O'Doherty
– volume: 113
  start-page: 202
  year: 1997
  ident: 10.1053/j.jvca.2013.05.028_bib8
  article-title: Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/S0022-5223(97)70416-1
  contributor:
    fullname: Farrar
– ident: 10.1053/j.jvca.2013.05.028_bib3
– volume: 3
  start-page: 604
  year: 2010
  ident: 10.1053/j.jvca.2013.05.028_bib4
  article-title: Right ventricular failure—A continuing problem in patients with left ventricular assist device support
  publication-title: J Cardiovasc Transl Res
  doi: 10.1007/s12265-010-9216-4
  contributor:
    fullname: John
– volume: 126
  start-page: 24
  year: 2010
  ident: 10.1053/j.jvca.2013.05.028_bib46
  article-title: Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2010.01.048
  contributor:
    fullname: Arcangeli
– volume: 106
  start-page: I198
  year: 2002
  ident: 10.1053/j.jvca.2013.05.028_bib10
  article-title: Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: Analysis of 245 patients
  publication-title: Circulation
  doi: 10.1161/01.cir.0000032906.33237.1c
  contributor:
    fullname: Ochiai
– volume: 25
  start-page: 1147
  year: 1999
  ident: 10.1053/j.jvca.2013.05.028_bib29
  article-title: Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension
  publication-title: Intensive Care Med
  doi: 10.1007/s001340051027
  contributor:
    fullname: Max
– volume: 90
  start-page: 353
  year: 1994
  ident: 10.1053/j.jvca.2013.05.028_bib19
  article-title: Does septal position affect right ventricular function during left ventricular assist in an experimental porcine model?
  publication-title: Circulation
  contributor:
    fullname: Hendry
– volume: 125
  start-page: 642
  year: 2003
  ident: 10.1053/j.jvca.2013.05.028_bib37
  article-title: Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1067/mtc.2003.107
  contributor:
    fullname: Hache
– volume: 12
  start-page: 715
  year: 1976
  ident: 10.1053/j.jvca.2013.05.028_bib42
  article-title: A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  publication-title: Prostaglandins
  doi: 10.1016/0090-6980(76)90048-4
  contributor:
    fullname: Moncada
– volume: 139
  start-page: 1316
  year: 2010
  ident: 10.1053/j.jvca.2013.05.028_bib5
  article-title: Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2009.11.020
  contributor:
    fullname: Kormos
– volume: 55
  start-page: 837
  year: 2010
  ident: 10.1053/j.jvca.2013.05.028_bib51
  article-title: Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation
  publication-title: Respir Care
  contributor:
    fullname: Ari
– volume: 41
  start-page: 425
  year: 1979
  ident: 10.1053/j.jvca.2013.05.028_bib43
  article-title: The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time
  publication-title: Thromb Haemost
  doi: 10.1055/s-0038-1646791
  contributor:
    fullname: Ubatuba
– volume: 38
  start-page: 198
  year: 1995
  ident: 10.1053/j.jvca.2013.05.028_bib28
  article-title: Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets
  publication-title: Pediatr Res
  doi: 10.1203/00006450-199508000-00011
  contributor:
    fullname: Zobel
– volume: 120
  start-page: S215
  year: 2009
  ident: 10.1053/j.jvca.2013.05.028_bib21
  article-title: Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.844274
  contributor:
    fullname: Pal
– volume: 114
  start-page: 780
  year: 1998
  ident: 10.1053/j.jvca.2013.05.028_bib35
  article-title: Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance
  publication-title: Chest
  doi: 10.1378/chest.114.3.780
  contributor:
    fullname: Haraldsson
– volume: 25
  start-page: 1
  year: 2006
  ident: 10.1053/j.jvca.2013.05.028_bib12
  article-title: Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure
  publication-title: J Heart Lung Transplant
  doi: 10.1016/j.healun.2005.07.008
  contributor:
    fullname: Dang
– volume: 15
  start-page: 637
  year: 1978
  ident: 10.1053/j.jvca.2013.05.028_bib44
  article-title: De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline
  publication-title: Prostaglandins
  doi: 10.1016/0090-6980(78)90059-X
  contributor:
    fullname: Gryglewski
– volume: 160
  start-page: 600
  year: 1999
  ident: 10.1053/j.jvca.2013.05.028_bib32
  article-title: Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.160.2.9810008
  contributor:
    fullname: Olschewski
– volume: 19
  start-page: 559
  year: 2006
  ident: 10.1053/j.jvca.2013.05.028_bib41
  article-title: A novel echocardiographic Doppler method for estimation of pulmonary arterial pressures
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2005.12.020
  contributor:
    fullname: Friedberg
– volume: 131
  start-page: 447
  year: 2006
  ident: 10.1053/j.jvca.2013.05.028_bib14
  article-title: Duration of inotropic support after left ventricular assist device implantation: Risk factors and impact on outcome
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2005.09.031
  contributor:
    fullname: Schenk
– volume: 51
  start-page: 2163
  year: 2008
  ident: 10.1053/j.jvca.2013.05.028_bib15
  article-title: The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2008.03.009
  contributor:
    fullname: Matthews
– volume: 99
  start-page: 466
  year: 2008
  ident: 10.1053/j.jvca.2013.05.028_bib47
  article-title: P2 receptors, platelet function and pharmacological implications
  publication-title: Thromb Haemost
  doi: 10.1160/TH07-11-0673
  contributor:
    fullname: Gachet
– volume: 61
  start-page: 626
  year: 1980
  ident: 10.1053/j.jvca.2013.05.028_bib18
  article-title: Leftward septal displacement during right ventricular loading in man
  publication-title: Circulation
  doi: 10.1161/01.CIR.61.3.626
  contributor:
    fullname: Brinker
– volume: 25
  start-page: 329
  year: 1993
  ident: 10.1053/j.jvca.2013.05.028_bib27
  article-title: PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction
  publication-title: Eur Surg Res
  doi: 10.1159/000129297
  contributor:
    fullname: Welte
– volume: 37
  start-page: 183
  year: 2001
  ident: 10.1053/j.jvca.2013.05.028_bib38
  article-title: Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(00)01102-5
  contributor:
    fullname: Ghio
– volume: 26
  start-page: 188
  year: 2000
  ident: 10.1053/j.jvca.2013.05.028_bib1
  article-title: Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass
  publication-title: Intensive Care Med
  doi: 10.1007/s001340050044
  contributor:
    fullname: Haraldsson
– volume: 12
  start-page: 420
  year: 2010
  ident: 10.1053/j.jvca.2013.05.028_bib17
  article-title: Diagnosis and management of right-sided heart failure in subjects supported with left ventricular assist devices
  publication-title: Curr Treat Options Cardiovasc Med
  doi: 10.1007/s11936-010-0091-8
  contributor:
    fullname: Romano
– volume: 30
  start-page: 870
  year: 2011
  ident: 10.1053/j.jvca.2013.05.028_bib26
  article-title: Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial
  publication-title: J Heart Lung Transplant
  contributor:
    fullname: Potapov
– volume: 10
  start-page: 864
  year: 1996
  ident: 10.1053/j.jvca.2013.05.028_bib34
  article-title: Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: A pharmacodynamic study
  publication-title: J Cardiothorac Vasc Anesth
  doi: 10.1016/S1053-0770(96)80047-4
  contributor:
    fullname: Haraldsson
– volume: 127
  start-page: 1058
  year: 2004
  ident: 10.1053/j.jvca.2013.05.028_bib36
  article-title: Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2003.11.035
  contributor:
    fullname: De Wet
– volume: 18
  start-page: 1499
  year: 1997
  ident: 10.1053/j.jvca.2013.05.028_bib33
  article-title: An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension
  publication-title: Eur Heart J
  doi: 10.1093/oxfordjournals.eurheartj.a015478
  contributor:
    fullname: Mikhail
– volume: 11
  start-page: 323
  year: 1983
  ident: 10.1053/j.jvca.2013.05.028_bib20
  article-title: The right ventricle: Physiologic and pathophysiologic considerations
  publication-title: Crit Care Med
  doi: 10.1097/00003246-198305000-00002
  contributor:
    fullname: Weber
– volume: 48
  start-page: 924
  year: 2001
  ident: 10.1053/j.jvca.2013.05.028_bib30
  article-title: Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit
  publication-title: Can J Anaesth
  doi: 10.1007/BF03017361
  contributor:
    fullname: Hache
SSID ssj0011557
Score 2.2599216
Snippet Objective Several strategies have been used to reduce the incidence of right ventricular failure after left ventricular assist device (LVAD) placement,...
Several strategies have been used to reduce the incidence of right ventricular failure after left ventricular assist device (LVAD) placement, including...
OBJECTIVESeveral strategies have been used to reduce the incidence of right ventricular failure after left ventricular assist device (LVAD) placement,...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 652
SubjectTerms Administration, Inhalation
Aged
Aged, 80 and over
Anesthesia & Perioperative Care
Arterial Pressure - drug effects
Blood Coagulation - drug effects
blood loss
Blood Loss, Surgical - prevention & control
Blood Transfusion - statistics & numerical data
Critical Care
Epoprostenol - administration & dosage
Epoprostenol - therapeutic use
Female
Heart-Assist Devices
Humans
inhaled epoprostenol
left ventricular assist device
Male
Middle Aged
prostacyclin
Pulmonary Artery - drug effects
pulmonary artery pressure
Retrospective Studies
Vasodilator Agents - administration & dosage
Vasodilator Agents - therapeutic use
Title Effects of Early Inhaled Epoprostenol Therapy on Pulmonary Artery Pressure and Blood Loss During LVAD Placement
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1053077013003030
https://dx.doi.org/10.1053/j.jvca.2013.05.028
https://www.ncbi.nlm.nih.gov/pubmed/24103713
https://search.proquest.com/docview/1535214219
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS-QwFD4MCsu-LOteZ70QwbelTtukTfs43hh1FGFnFt9CpklQkXaYi-CLv91z0nZgWfXBp9KSNunJuSbnfAHYizJjJJrSAEUnDIQzJkA7zmndapLYuCgiv6B_cZkOxuLsOrnuwGFbC0NplY3ur3W619bNk15Dzd709rb3Bz0DZFBJW2_IqZzidpGEdIrB_tMqzQMdHo_2SY0Dat0UzuBt727_7qEg7KGIe_ROOpH9ZeP0mvPpjdDJZ_jUeI-sXw9wAzq2_AIfLpr98a9Q1WDEc1Y55qGL2Wl5gybAsONpNaUCD1tW92xUQwmwqmRXy3tkRD17pI9avNT1gjPLdGnYAaW1syGOlR35ekY2_Ns_Yle09k7Lit9gfHI8OhwEzZEKQSGkXAQ6ts7GMhKJE3GYOzOJZVygDAuHrkIkUy3khBdULpukDsNFodNcci6cC6VzOf8Oa2VV2p_AQu0cTqjOMYISmct1VkhhiszmQmapibvwu6WlmtbIGcrveCccIw6ivCLKqzBRSPkuyJbcqq0JRS1m541IzVWk5rEK1X_T3oVk9eY_nKPQKLzZ4247qwpFivZJdGmrJfZEkDeRQF3ehR_1dK_-AB0eAjnkv97Z6yZ8xDtRJ5ttwdpitrTb6NYsJjueb3dgvX96Prh8BniC9Fo
link.rule.ids 314,780,784,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hkIBLBX3QLS01Um9V2CR24uRIeWiBXYTEUnGzvLGtglCy2gcSF357Z5xkJcTjwClK4sTOeDxPzxeAX1FmjERVGuDSCQPhjAlQj3OKW40SGxdF5AP6g_O0dyVOr5PrJThoa2FoW2Uj-2uZ7qV1c6XbULM7vrnpXqJlgAwqKfWGnMrRb18RCVq_yNR7j4t9HmjxeLhPah1Q86ZyBk-7t3u39wWBD0Xcw3fSL9lf1k6vWZ9eCx1vwIfGfGT79Qg3YcmWH2F10CTIP0FVoxFPWeWYxy5mJ-U_1AGGHY2rMVV42LK6Y8MaS4BVJbuY3yEn6skDvdTioS4YnFimS8P-0L521sexskNf0Mj6f_cP2QUF3ymu-Bmujo-GB72g-adCUAgpZ4GOrbOxjETiRBzmzoxiGRe4iIVDWyGSqRZyxAuql01Sh_6i0GkuORfOhdK5nH-B5bIq7VdgoXYOZ1Tn6EKJzOU6K6QwRWZzIbPUxB343dJSjWvoDOVT3glHl4Mor4jyKkwUUr4DsiW3aotCUYzZabOmpipS01iF6tm8dyBZPPmEdRRqhTd73G1nVeGaokSJLm01x54I8yYSKMw7sFVP9-IL0OIhlEP-7Z29_oS13nDQV_2T87NtWMc7ot559h2WZ5O5_YE2zmy043n4Pzkd9fc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Early+Inhaled+Epoprostenol+Therapy+on+Pulmonary+Artery+Pressure+and+Blood+Loss+During+LVAD+Placement&rft.jtitle=Journal+of+cardiothoracic+and+vascular+anesthesia&rft.au=Groves%2C+Danja+S.%2C+MD%2C+PhD&rft.au=Blum%2C+Franziska+E.%2C+MD&rft.au=Huffmyer%2C+Julie+L.%2C+MD&rft.au=Kennedy%2C+Jamie+L.W.%2C+MD&rft.date=2014-06-01&rft.issn=1053-0770&rft.volume=28&rft.issue=3&rft.spage=652&rft.epage=660&rft_id=info:doi/10.1053%2Fj.jvca.2013.05.028&rft.externalDBID=ECK1-s2.0-S1053077013003030&rft.externalDocID=1_s2_0_S1053077013003030
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10530770%2FS1053077013X00102%2Fcov150h.gif